Propofol chemical structure20 ml ampoule of 1% propofol emulsion
Find information on thousands of medical conditions and prescription drugs.

Diprivan

Propofol is a short-acting intravenous anesthetic agent used for the induction of general anesthesia in adult patients and pediatric patients older than 3 years of age; maintenance of general anesthesia in adult patients and pediatric patients older than 2 months of age; and intensive care unit (ICU) sedation for intubated, mechanically ventilated adults. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Propofol is approved for the induction and maintenance of anesthesia in more than 50 countries.

Initial clinical trials were in 1977, in a form solubilised in cremophor EL, but due to anaphylactic reactions it was withdrawn from the market. It was subsequently reformulated as an aqueous emulsion in intralipid and re-launched in 1986 by AstraZeneca with the brand name Diprivan. The current preparation is 1% propofol solubilised with 2.25% glycerol, 10% soybean oil and 1.2% purified egg phospholipid, and has a pH between 6.0 and 8.5 and a pKa of 11. Diprivan contains EDTA as an antimicrobial agent. Newer generic formulations contain sodium metabisulfite or benzyl alcohol.

It is highly protein bound in vivo and is metabolised by conjugation in the liver. Its rate of clearance exceeds hepatic blood flow, suggesting an extrahepatic site of elimination as well. Its mechanism of action is uncertain, but it is postulated that its primary effect may be at the GABA-A receptor.

Aside from the hypotension and transient apnea following induction doses, one of its most frequent side-effects is pain on injection, especially in smaller veins. This pain can be mitigated by pretreatment or mixing with intravenous lidocaine. Alternative formulations with a larger proportion of medium-chain triglycerides (as opposed to Intralipid) appear to have less pain on injection, possibly due to lower concentrations of free aqueous propofol.

It appears to be safe for use in porphyria, and has not been known to trigger malignant hyperpyrexia. The elimination half-life of propofol has been estimated to be between 2-24 hours. However, its duration of clinical effect is much shorter because propofol is rapidly distributed into peripheral tissues.

Read more at Wikipedia.org


[List your site here Free!]


Diary from a Week in Practice
From American Family Physician, 9/1/00 by Walter L. Larimore

Monday

"Doc," exclaimed the happy patient, "I did it myself. I'm as good as you are." This elderly man was described by WLL in a past edition of "Diary" (September 15, 1994). He was WLL's first "cure" of benign positional vertigo (BPV) using the Epley maneuver. The "canalith repositioning procedure" is for the in-office treatment of BPV. WLL reported that "this maneuver is extremely easy to perform, takes less than 10 minutes, usually causes no patient discomfort, requires no medication and was learned by reading a single paper from the literature." He has found that in many cases, the symptoms are immediately quelled by the procedure. Now comes a report that patients can perform a modification of this procedure themselves (Neurology 1999;53:1358-60). According to the report, symptoms resolved within seven days in 18 of 28 patients (64 percent) who performed a modified version of the Epley procedure three times a day until the BPV was gone. Instructions and diagrams can be found at a Web site (http://www. charite.de/ch/neuro/vertigo.html). You can choose instructions depending on whether the right or left ear is affected. A more detailed review of the Epley procedure can be found in the New England Journal of Medicine (1999;341:1590-6).

Tuesday

WLL remembers a case he was involved in several years ago. Although a mystery then, it seems much clearer now. At that time, the young couple who had sat in front of WLL was frustrated. Although they had previously achieved pregnancy quickly and already had two children, they had been trying to conceive again for more than a year without success. The only change in their history was his hypertension (well-controlled with a low-dose, sustained-release formulation of nifedipine). He had improved his nutrition and his weight. Physicians' Desk Reference indicated no sexual or reproductive effects of nifedipine. The couple wanted something done. WLL decided to temporize and suggested that the husband consider a trial period off the nifedipine. His blood pressure stayed normal off the medication, and her pregnancy test was positive within three months. WLL didn't think about this case again until he read about a presentation given at the American Society for Reproductive Medicine that discussed the reversible male infertility state produced by nifedipine--apparently with few side effects. Researchers say the use of nifedipine produces infertility within one month and the infertility is reversed within three months of stopping the drug.

Wednesday

"Doc, please let me out of here!" were the words that greeted JTL today while visiting one of his patients during hospital rounds. The patient, a 39-year-old man previously in excellent health, had been admitted with complaint of left-sided facial numbness as well as "pressure" in the upper right arm. A neurologist had been consulted and had ordered a computed tomographic (CT) scan of the head and carotid Doppler studies. As the patient was speaking, JTL could see that there was a definite hemifacial palsy that involved the forehead. JTL recalled the phrase he had heard often from his neuroanatomy professor while he was at George Washington University School of Medicine: "A central 7th [nerve lesion] spares the forehead." In this patient's case, it was clear that the cause of the symptoms was a peripheral lesion (e.g., Bell's palsy) rather than a central 7th cranial nerve lesion, because of the involvement of the forehead on the affected side. As for the transient right arm complaints, JTL could recall that left-sided facial symptoms do not anatomically correlate with right-sided arm complaints--and the normal head CT scan further proved this point. JTL was happy to let this patient leave the hospital and was not at all surprised to learn the following day that the carotid Doppler study revealed no disease.

Thursday

A new fact sheet titled "What Works for Congestive Heart Failure?" reviews available literature for three common alternative therapies. For coenzyme Q10, it was concluded that it "appears to be a promising agent in the symptomatic treatment of congestive heart failure." In controlled trials, patients who are New York Heart Association (NYHA) class III and IV benefit from dosages of 50 to 150 mg per day (up to 2 mg per kg per day). Because a mortality benefit has not been demonstrated with Q10, the authors concluded, "inhibitors, diuretics, digoxin and beta blockers should remain the cornerstones of therapy." The review also discusses hawthorne, a positive inotrope that has been used to improve cardiac output and exercise tolerance in patients with heart failure. According to the Natural Medicine's Comprehensive Database, hawthorne may have some advantages over digoxin in mild heart failure (stage II NYHA) but is inappropriate in more advanced stages. The dosage range is 160 to 900 mg of standardized extract per day. Lastly, the review looked at L-carnitine and concluded, "it is not clear whether L-carnitine provides any benefit beyond well-established therapies." Because these therapies are not regulated in the United States, be sure that your patients, if they choose to use them, use reputable brands produced to USP specifications.

Friday

JTL, often accused of being "hypersensitive" to his surroundings, today noted a distinct change when he sat in the examination rooms with his patients, yet could not put his finger on the culprit. Finally, while standing at his podium, he was approached by his nurse, who remarked, "How do you like the music?" JTL realized that he was listening to the smooth strains of Frank Sinatra, Harry Belafonte and Tommy Dorsey rather than the contemporary hits of previous weeks. While background music may not be an issue for many other physicians, JTL believes that patients are likely affected by the music they listen to while waiting. JTL has found this switch to music of bygone years a soothing influence. Later that day, while counseling one of his patients who has been under significant stress, JTL heard the song that had been played at JTL's wedding reception. The song reminded JTL to share with his patient the need to keep marriage fresh and romantic, and suggested to the patient that he and his wife begin to put aside at least one evening a month for a "date night." The suggestion was most welcomed by the patient, who recognized that he had indeed been growing apart from his wife and family.

Saturday/Sunday

In an earlier "Diary," JTL shared the story of Clyde who, newly diagnosed with lung cancer, required emergency intubation and mechanical ventilation after developing acute respiratory failure. As JTL had predicted, Clyde was unable to be weaned off the ventilator without developing respiratory failure. Hence, continual sedation had been the rule over the past week. Today, on Clyde's 62nd birthday, all concerned had agreed to remove Clyde from life support. JTL, after visiting at length with Clyde's wife and children, received their approval. After weaning Clyde off Diprivan, JTL, in the presence of Clyde's wife, witnessed the "nod" to go ahead with extubation. Following prayer with the family, Clyde was extubated, and a nonrebreathing oxygen mask placed over his mouth and nose. The family and nurses sang "Happy Birthday," and a small piece of cake was placed on his tongue. JTL watched in awe as Clyde beamed, his color having actually improved. After writing orders to transfer Clyde out of the ICU, JTL turned to leave. Clyde's wife ran to JTL and asked him to return to the room, where Clyde, despite his inability to speak following so many days of intubation, mouthed the words, "Thank you." The next day JTL returned to the hospital to pronounce Clyde's death, a death that, all things considered, was as peaceful as any death that JTL had ever witnessed.

This is one in a series by Walter L. Larimore, M.D., John R. Hartman, M.D., and John T. Littell, M.D., three family physicians in private practice in Kissimmee, Fla.

COPYRIGHT 2000 American Academy of Family Physicians
COPYRIGHT 2000 Gale Group

Return to Diprivan
Home Contact Resources Exchange Links ebay